Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-08-20
DOI
10.3389/fimmu.2021.669965
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy
- (2019) Bernardo Rapoport et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy
- (2018) David A. Bernal-Estévez et al. BMC CANCER
- Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
- (2018) Lina Liu et al. MOLECULAR THERAPY
- Dendritic cell-based immunotherapy: a basic review and recent advances
- (2017) João Constantino et al. IMMUNOLOGIC RESEARCH
- Immunogenic tumor cell death induced by chemotherapy in patients with breast cancer and esophageal squamous cell carcinoma
- (2017) Keita Aoto et al. ONCOLOGY REPORTS
- Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1
- (2017) François Bertucci et al. Current Oncology Reports
- Trial watch: Dendritic cell-based anticancer immunotherapy
- (2017) Abhishek D. Garg et al. OncoImmunology
- Chemotherapy and radiation therapy elicits tumor specific T cell responses in a breast cancer patient
- (2016) David Bernal-Estévez et al. BMC CANCER
- Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2 pos DCIS Independent of Route: Results of Randomized Selection Design Trial
- (2016) Lea Lowenfeld et al. CLINICAL CANCER RESEARCH
- High-density preculture of PBMCs restores defective sensitivity of circulating CD8 T cells to virus- and tumor-derived antigens
- (2015) J. Wegner et al. BLOOD
- Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis
- (2015) Jacob H. Levine et al. CELL
- FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data
- (2015) Sofie Van Gassen et al. CYTOMETRY PART A
- Mapping the effects of drugs on the immune system
- (2015) Brian A Kidd et al. NATURE BIOTECHNOLOGY
- Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy
- (2015) Sylvain Ladoire et al. OncoImmunology
- Clinical use of dendritic cells for cancer therapy
- (2014) Sébastien Anguille et al. LANCET ONCOLOGY
- Blockade of mTOR Signaling via Rapamycin Combined with Immunotherapy Augments Antiglioma Cytotoxic and Memory T-Cell Functions
- (2014) Y. Mineharu et al. MOLECULAR CANCER THERAPEUTICS
- Automated identification of stratifying signatures in cellular subpopulations
- (2014) Robert V. Bruggner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
- (2014) Elisavet Paplomata et al. Therapeutic Advances in Medical Oncology
- Blockade of PD-1/PD-L1 immune checkpoint during DC vaccination induces potent protective immunity against breast cancer in hu-SCID mice
- (2013) Yan Ge et al. CANCER LETTERS
- Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization
- (2013) Evan W Newell et al. NATURE BIOTECHNOLOGY
- viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia
- (2013) El-ad David Amir et al. NATURE BIOTECHNOLOGY
- Automatic Classification of Cellular Expression by Nonlinear Stochastic Embedding (ACCENSE)
- (2013) K. Shekhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
- (2012) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy
- (2012) Morten Hansen et al. VACCINE
- A Novel Dendritic Cell-based Immunization Approach for the Induction of Durable Th1-polarized Anti-HER-2/neu Responses in Women With Early Breast Cancer
- (2011) Gary K. Koski et al. JOURNAL OF IMMUNOTHERAPY
- Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE
- (2011) Peng Qiu et al. NATURE BIOTECHNOLOGY
- A human memory T cell subset with stem cell–like properties
- (2011) Luca Gattinoni et al. NATURE MEDICINE
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data
- (2010) Yu Qian et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition
- (2010) C Ji et al. ONCOGENE
- Chemotherapy and radiotherapy: Cryptic anticancer vaccines
- (2010) Yuting Ma et al. SEMINARS IN IMMUNOLOGY
- Tumor-Infiltrating Regulatory Dendritic Cells Inhibit CD8+ T Cell Function via L-Arginine Metabolism
- (2009) L. A. Norian et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now